G. Amer

489 total citations
8 papers, 271 citations indexed

About

G. Amer is a scholar working on Psychiatry and Mental health, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Amer has authored 8 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Physiology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Amer's work include Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). G. Amer is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). G. Amer collaborates with scholars based in Spain, Netherlands and Egypt. G. Amer's co-authors include Cristóbal Carnero Pardo, E. Tolosa, Rafael Oliva, Pau Pástor, Judith Allardyce, Inez Myin‐Germeys, Marta Galdós, Aranzazu Fernández‐Rivas, Tineke Lataster and Marieke Wichers and has published in prestigious journals such as Annals of Neurology, Journal of Neurology Neurosurgery & Psychiatry and Schizophrenia Bulletin.

In The Last Decade

G. Amer

8 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Amer Spain	6	139	125	68	67	57	8	271
Alexandrine Corriger France	6	40 0.3×	65 0.5×	60 0.9×	46 0.7×	33 0.6×	9	327
Janet Sangare United States	7	103 0.7×	28 0.2×	52 0.8×	20 0.3×	86 1.5×	10	408
Haritz Jiménez‐Urbieta Spain	11	281 2.0×	66 0.5×	48 0.7×	65 1.0×	42 0.7×	16	405
Patrizia Ferrero Italy	9	90 0.6×	52 0.4×	94 1.4×	36 0.5×	88 1.5×	17	336
Luisa Mari Italy	8	67 0.5×	40 0.3×	76 1.1×	16 0.2×	56 1.0×	10	224
Merle C. Hoenig Germany	10	116 0.8×	167 1.3×	149 2.2×	50 0.7×	40 0.7×	19	376
Thea P. Lillethorup Denmark	11	191 1.4×	109 0.9×	53 0.8×	34 0.5×	48 0.8×	18	356
Sabrina A.M. Curcio Italy	11	129 0.9×	169 1.4×	76 1.1×	67 1.0×	163 2.9×	16	353
George Carr Canada	6	101 0.7×	58 0.5×	41 0.6×	19 0.3×	76 1.3×	7	350
Cindie Courtin France	12	16 0.1×	73 0.6×	66 1.0×	36 0.5×	146 2.6×	21	396

Countries citing papers authored by G. Amer

Since Specialization

Citations

This map shows the geographic impact of G. Amer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Amer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Amer more than expected).

Fields of papers citing papers by G. Amer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Amer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Amer. The network helps show where G. Amer may publish in the future.

Co-authorship network of co-authors of G. Amer

This figure shows the co-authorship network connecting the top 25 collaborators of G. Amer. A scholar is included among the top collaborators of G. Amer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Amer. G. Amer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Amer, G., A Leiva, Joana Ripoll, et al.. (2019). Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM). BMC Geriatrics. 19(1). 101–101. 8 indexed citations

Rubí, S., et al.. (2018). Concordance between brain 18 F-FDG PET and cerebrospinal fluid biomarkers in diagnosing Alzheimer's disease. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 37(1). 3–8. 6 indexed citations

Rubí, S., et al.. (2017). Concordancia entre la PET cerebral con 18 F-FDG y los biomarcadores en líquido cefalorraquídeo en el diagnóstico de enfermedad de Alzheimer. Revista Española de Medicina Nuclear e Imagen Molecular. 37(1). 3–8. 4 indexed citations

Suárez‐Calvet, Marc, Oriol Dols‐Icardo, Albert Lladó, et al.. (2013). Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 684–691. 59 indexed citations

Galdós, Marta, Claudia J.P. Simons, Aranzazu Fernández‐Rivas, et al.. (2010). Affectively Salient Meaning in Random Noise: A Task Sensitive to Psychosis Liability. Schizophrenia Bulletin. 37(6). 1179–1186. 55 indexed citations

Blesa, Rafael, Javier Olascoaga, G. Amer, et al.. (2006). [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].. PubMed. 21(6). 289–96. 3 indexed citations

Pástor, Pau, et al.. (2001). Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Annals of Neurology. 49(2). 263–267. 112 indexed citations

Amer, G., et al.. (1995). Undetected neuropsychophysiological sequelae of khat chewing in standard aviation medical examination.. PubMed. 66(8). 739–44. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact